decisionhealth Newsletters, Coder Pink Sheets - 2006 Issue 7 (July)
Gardasil: New $400-plus vaccine is here
Subscribe or sign in to view the full article.
Article Overview
This article discusses the rollout of Gardasil, an HPV vaccine introduced for prevention-related care, and the practical coverage and purchasing questions it raised for pediatric practices. It is aimed at coders, billers, pediatric offices, and revenue cycle staff who need to understand the general billing context and the newly referenced code set item tied to the vaccine product.
Why This Topic Matters
New vaccines can affect documentation, inventory planning, payer coverage decisions, and billing workflows. This article helps readers recognize the general reimbursement and operational issues surrounding an early HPV vaccine adoption period.
What You Will Learn
- The clinical and preventive-care context for a newly approved HPV vaccine
- Why vaccine coverage and pricing were immediate operational concerns for practices
- How a new vaccine-related billing code was being discussed in the article's timeframe
- Which provider specialties were most likely to administer the vaccine
Who Should Read This
- Medical coders
- Billers
- Pediatric practice administrators
- Revenue cycle staff
- Clinical office managers
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com